For the past three decades, apolipoprotein E (APOE) has been known as the single greatest
genetic modulator of sporadic Alzheimer disease (AD) risk, influencing both the average age …

Abstract The Alzheimer's Association hosted the second Latinos & Alzheimer's Symposium
in May 2021. Due to the COVID‐19 pandemic, the meeting was held online over 2 days, with …

Dementia is more prevalent in Blacks than in Whites, likely due to a combination of
environmental and biological factors. Paradoxically, clinical studies suggest an attenuation …

Timely and accurate diagnosis of Alzheimer's disease (AD) in clinical practice remains
challenging. PET and CSF biomarkers are the most widely used biomarkers to aid diagnosis …

Background Sleep phenotypes have been reported to be associated with cognitive ageing
outcomes. However, there is limited research using genetic variants as proxies for sleep …

Objective. The clinical value of intestinal flora balance therapy based on probiotic support in
improving cognitive function and symptoms of patients with Alzheimer's disease was to …

INTRODUCTION At the Alzheimer's Association's APOE and Immunity virtual conference,
held in October 2021, leading neuroscience experts shared recent research advances on …

Background NeuroEPO plus is a recombinant human erythropoietin without erythropoietic
activity and shorter plasma half-life due to its low sialic acid content. NeuroEPO plus …

The sex and APOE4 genotype are significant risk factors for Alzheimer's disease (AD);
however, the mechanism (s) responsible for this interaction are still a matter of debate. Here …

Abstract Introduction Apolipoprotein E (APOE) is considered the major susceptibility gene for
developing Alzheimer's disease. However, the strength of this risk factor is not well …